Literature DB >> 22527599

Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP).

Gary Wang1, Keesandra Agenor, Justine Pizot, Donald P Kotler, Yaniv Harel, Bart J Van Der Schueren, Iliana Quercia, James McGinty, Blandine Laferrère.   

Abstract

BACKGROUND: Following gastric bypass surgery (GBP), there is a post-prandial rise of incretin and satiety gut peptides. The mechanisms of enhanced incretin release in response to nutrients after GBP is not elucidated and may be in relation to altered nutrient transit time and/or malabsorption.
METHODS: Seven morbidly obese subjects (BMI = 44.5 ± 2.8 kg/m(2)) were studied before and 1 year after GBP with a D: -xylose test. After ingestion of 25 g of D: -xylose in 200 mL of non-carbonated water, blood samples were collected at frequent time intervals to determine gastric emptying (time to appearance of D: -xylose) and carbohydrate absorption using standard criteria.
RESULTS: One year after GBP, subjects lost 45.0 ± 9.7 kg and had a BMI of 27.1 ± 4.7 kg/m(2). Gastric emptying was more rapid after GBP. The mean time to appearance of D: -xylose in serum decreased from 18.6 ± 6.9 min prior to GBP to 7.9 ± 2.7 min after GBP (p = 0.006). There was no significant difference in absorption before (serum D: -xylose concentrations = 35.6 ± 12.6 mg/dL at 60 min and 33.9 ± 9.1 mg/dL at 180 min) or 1 year after GBP (serum D: -xylose = 31.5 ± 18.1 mg/dL at 60 min and 27.2 ± 11.9 mg/dL at 180 min).
CONCLUSIONS: These data confirm the acceleration of gastric emptying for liquid and the absence of carbohydrate malabsorption 1 year after GBP. Rapid gastric emptying may play a role in incretin response after GBP and the resulting improved glucose homeostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22527599      PMCID: PMC3659340          DOI: 10.1007/s11695-012-0656-6

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  27 in total

Review 1.  D-xylose testing.

Authors:  R M Craig; E D Ehrenpreis
Journal:  J Clin Gastroenterol       Date:  1999-09       Impact factor: 3.062

2.  Fate of pancreatic enzymes during small intestinal aboral transit in humans.

Authors:  P Layer; V L Go; E P DiMagno
Journal:  Am J Physiol       Date:  1986-10

3.  Gastric emptying rate after gastric bypass and gastroplasty.

Authors:  I Näslund; K W Beckman
Journal:  Scand J Gastroenterol       Date:  1987-03       Impact factor: 2.423

Review 4.  Intestinal effects of alpha-glucosidase inhibitors: absorption of nutrients and enterohormonal changes.

Authors:  B Göke; C Herrmann; R Göke; H C Fehmann; P Berghöfer; G Richter; R Arnold
Journal:  Eur J Clin Invest       Date:  1994-08       Impact factor: 4.686

5.  Mechanisms of satiety and gastric emptying after gastric partitioning and bypass.

Authors:  H V Villar; S L Wangenteen; T F Burks; D D Patton
Journal:  Surgery       Date:  1981-08       Impact factor: 3.982

6.  Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.

Authors:  Reawika Chaikomin; Selena Doran; Karen L Jones; Christine Feinle-Bisset; Deirdre O'Donovan; Christopher K Rayner; Michael Horowitz
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-05-10       Impact factor: 4.310

7.  Carbohydrate malabsorption. Its measurement and its contribution to diarrhea.

Authors:  H F Hammer; K D Fine; C A Santa Ana; J L Porter; L R Schiller; J S Fordtran
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

8.  Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose).

Authors:  C Qualmann; M A Nauck; J J Holst; C Orskov; W Creutzfeldt
Journal:  Scand J Gastroenterol       Date:  1995-09       Impact factor: 2.423

9.  Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy.

Authors:  J Miholic; C Orskov; J J Holst; J Kotzerke; H J Meyer
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

10.  Magnitude and variability of the glucagon-like peptide-1 response in patients with type 2 diabetes up to 2 years following gastric bypass surgery.

Authors:  Bart J Van der Schueren; Peter Homel; Mariam Alam; Keesandra Agenor; Gary Wang; David Reilly; Blandine Laferrère
Journal:  Diabetes Care       Date:  2011-11-28       Impact factor: 19.112

View more
  31 in total

1.  Effect of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding on gastrointestinal metabolism of ingested glucose.

Authors:  Faidon Magkos; David Bradley; J Christopher Eagon; Bruce W Patterson; Samuel Klein
Journal:  Am J Clin Nutr       Date:  2015-11-25       Impact factor: 7.045

Review 2.  Mechanisms underlying weight loss after bariatric surgery.

Authors:  Alexander D Miras; Carel W le Roux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

3.  Changes in intestinal permeability after Roux-en-Y gastric bypass.

Authors:  Alexandre Lages Savassi-Rocha; Marco Túlio Costa Diniz; Eduardo Garcia Vilela; Maria de Fátima Haueisen Sander Diniz; Soraya Rodrigues de Almeida Sanches; Aloísio Sales da Cunha; Maria de Lourdes de Abreu Ferrari; Henrique Oswaldo da Gama Torres; Bruno Antonio Maciente; Gabriela Santana Ataliba; Paloma Maciel Araújo; Taciana Bretas Guerra; Inara Kellen Fonseca Balbino
Journal:  Obes Surg       Date:  2014-02       Impact factor: 4.129

4.  Impact of Oral-Cecal Transit Time on the Interpretation of Lactulose Breath Tests After RYGB: a Personalized Approach to the Diagnosis of SIBO.

Authors:  Pichamol Jirapinyo; Tracy T Makuvire; William Y Dong; Walter W Chan; Christopher C Thompson
Journal:  Obes Surg       Date:  2019-03       Impact factor: 4.129

5.  Gastric Emptying and Food Tolerance Following Banded and Non-banded Roux-en-Y Gastric Bypass.

Authors:  Galzuinda Maria Figueiredo Reis; Carlos Alberto Malheiros; Paulo Roberto Savassi-Rocha; Omar Lopes Cançado Júnior; Fábio Rodrigues Thuler; Mauro Lima Faria; Vicente Guerra Filho
Journal:  Obes Surg       Date:  2019-02       Impact factor: 4.129

Review 6.  Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?

Authors:  Jean Debédat; Chloé Amouyal; Judith Aron-Wisnewsky; Karine Clément
Journal:  Semin Immunopathol       Date:  2019-04-25       Impact factor: 9.623

7.  Long-Term Food Tolerance After Bariatric Surgery: Comparison of Three Different Surgical Techniques.

Authors:  Oscar Cano-Valderrama; Andrés Sánchez-Pernaute; Miguel A Rubio-Herrera; Inmaculada Domínguez-Serrano; Antonio J Torres-García
Journal:  Obes Surg       Date:  2017-11       Impact factor: 4.129

Review 8.  Gut feelings about diabetes.

Authors:  Blandine Laferrère
Journal:  Endocrinol Nutr       Date:  2012-03-03

9.  Prospective evaluation of insulin and incretin dynamics in obese adults with and without diabetes for 2 years after Roux-en-Y gastric bypass.

Authors:  Jonathan Q Purnell; Geoffrey S Johnson; Abdus S Wahed; Chiara Dalla Man; Francesca Piccinini; Claudio Cobelli; Ronald L Prigeon; Bret H Goodpaster; David E Kelley; Myrlene A Staten; Karen E Foster-Schubert; David E Cummings; David R Flum; Anita P Courcoulas; Peter J Havel; Bruce M Wolfe
Journal:  Diabetologia       Date:  2018-02-10       Impact factor: 10.122

10.  Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.

Authors:  Ina Gesquiere; Adam S Darwich; Bart Van der Schueren; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Amin Rostami; Veerle Foulon; Patrick Augustijns
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.